09:55 EDT VistaGen Therapeutics trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VTGN:
- Vistagen upgraded to Buy at Maxim after SAD trial succeeds
- Vistagen upgraded to Buy from Hold at Maxim
- Vistagen skyrockets after social anxiety disorder trial hits primary endpoint
- Vistagen (NASDAQ:VTGN) Skyrockets over 600% on Positive Phase 3 Data for Social Anxiety Disorder
- VistaGen Therapeutics trading resumes
Questions or Comments about the article? Write to editor@tipranks.com